Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:17 PM ET 8-K
Nasdaq/NYSE Compliance Notice Datavault AI Inc. DVLT

Datavault AI Nasdaq/NYSE Compliance Notice

Datavault AI received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement and a closing bid price below $0.10 for ten consecutive business days. Trading on Nasdaq will be suspended effective November 17, 2026, at which point the company expects its common stock to begin trading on the OTC Markets. The company intends to request a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension to maintain its listing.

Counterparty
Nasdaq
5:17 PM ET 10-Q
Financial Results Nuvve Holding Corp. NVVE

Nuvve Holding Q3 2026 Results: Net Loss of $4.26M, Loss Narrows

Nuvve Holding Corp. reported a total revenue of $1.09 million for the quarter ended September 30, 2026, down from $1.60 million in the prior year period. The company experienced a net loss of $4.69 million for the quarter, contributing to a total stockholders' deficit of $13.42 million as of September 30, 2026.

Key figure
Net loss $4.26M
5:16 PM ET 8-K
Financial Results Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Financial Results

Cheetah Net Supply Chain Service reported Q3 2026 revenue of $3.56 million, an 883% increase year-over-year driven by its international trading business acquisition. Despite the revenue growth, the company reported a net loss from continuing operations of $2.55 million, primarily due to a $2.78 million non-cash loss from the change in fair value of acquisition-related contingent consideration.

Term
Q3 2026

“The third quarter of 2026 marked an important step forward in the execution of our business diversification strategy. Following the acquisition of Super International Trading Limited in May, our international trading business demonstrated encouraging momentum, generating approximately $3.56 million in revenue during the quarter.”

Tony Liu, Cheetah’s Chairman and CEO

“Looking ahead, we remain committed to disciplined capital allocation, prudent financial management, and the pursuit of strategic opportunities that complement our existing capabilities.”

Tony Liu, Cheetah’s Chairman and CEO
5:16 PM ET 8-K
Shareholder Meeting Azio AI Holdings, Inc. AZIO

Azio AI Holdings Shareholder Meeting

Azio AI Holdings held its 2026 Annual Meeting where stockholders approved the 2026 Equity Incentive Plan and several other proposals. The meeting was adjourned until December 4, 2026, specifically to address Proposal 4 regarding the issuance of common stock upon conversion of Series A Preferred Stock, pending Nasdaq listing application approval. Approximately 54.2% of outstanding shares were represented at the meeting, constituting a quorum.

5:15 PM ET 10-Q
Financial Results CaliberCos Inc. CWD

CaliberCos Q3 2026 Results: Net Loss of $5.03M, Loss Widens

CaliberCos Inc. reported a net loss of $18.0 million for the nine months ended September 30, 2026, compared to a $15.0 million loss in the prior year period. Total assets increased significantly to $178.9 million from $135.4 million at year-end 2025, primarily driven by the consolidation of new investment funds and real estate assets.

Key figure
Net loss $5.03M
5:15 PM ET 8-K
Capital Raise Airwa Inc. YYAI

Airwa Capital Raise of $1.5M

AiRWA Inc. entered into securities purchase agreements with certain investors to sell 1,800,000 shares of common stock at $0.8332 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for working capital and general corporate purposes. The offering was conducted as a private placement in reliance on Section 4(a)(2) and Regulation D.

Value
$1.5M
5:15 PM ET 10-Q
Financial Results Cumberland Pharmaceuticals Inc CPIX

Cumberland Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $77.8M

Cumberland Pharmaceuticals reported a significant net income of $77.8 million for the quarter ended September 30, 2026, primarily driven by an $81.1 million gain from the disposal of discontinued operations. Total revenue from continuing operations increased to $2.2 million, while the company declared a substantial cash dividend of $22.5 million during the period.

Key figure
Net income $77.8M
5:15 PM ET Form 4
Insider Selling Cricut, Inc. CRCT

Cricut CEO Arora Ashish Sells $1.83M of Stock

Arora Ashish, CEO, sold 210,000 shares of Cricut, Inc. at $8.58 to $8.95 a share (average $8.72) in 3 transactions, worth $1.83M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 4,698,740 (-1.5%).

Value
$1.83M
Shares
210,000
Average price
$8.72
Role
CEO
Holding change
-1.5%
Trade date
Nov 11, 2026 to Nov 13, 2026
5:15 PM ET 8-K
Financial Results Where Food Comes From, Inc. WFCF

Where Food Comes From Financial Results

Where Food Comes From reported Q3 2026 total revenue of $7.3M, up 4% year-over-year, driven by 6% growth in its core verification and certification business. Operating income grew 68% to $1.0M as gross margins expanded to 42.1% due to cost-reduction initiatives and service bundling. The company also returned $268,000 to shareholders through stock buybacks during the quarter.

Term
Q3 2026

“We are pleased to report strong third quarter financial results highlighted by 6% growth in our core verification and certification business that is benefitting from resurgent demand for beef-related services and growing momentum in other service offerings.”

John Saunders, Chairman and CEO

“Our profit metrics also showed continued strength with gross margins rising by 380 basis points to 42.1% and operating income growing 68% to $1.0 million from $600,000 a year ago – both reflecting the positive impact of our ongoing cost down initiatives in conjunction with accelerating revenue.”

John Saunders, Chairman and CEO
5:15 PM ET 10-Q
Financial Results Research Alliance Corp IV RACD

Research Alliance Corp IV Q3 2026 Results: Net Income $379K

Research Alliance Corp IV reported a net income of $379,042 for the quarter ended September 30, 2026, primarily driven by $534,815 in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $75,534,815 currently held in trust for its Class A ordinary shares.

Key figure
Net income $379K
5:14 PM ET 10-Q
Financial Results CIM Opportunity Zone Fund, L.P.

CIM Opportunity Zone Fund Q3 2026 Results: Net Income $7.87M, Up 42.0% YoY

CIM Opportunity Zone Fund, L.P. reported a net loss of $44.8 million for the nine months ended September 30, 2026, compared to a net income of $110.8 million in the prior year period. The decline was primarily driven by the absence of a $117.4 million realized gain on a lease investment recorded in 2025 and increased operating and interest expenses.

Key figure
Net income $7.87M · +42.0% YoY
5:14 PM ET Form 4
Insider Selling Korro Bio, Inc. KRRO

Korro Bio Director Jean Francois Formela Sells $964K of Stock

Jean Francois Formela, Director, sold 66,015 shares of Korro Bio, Inc. at $14.30 to $15.60 a share (average $14.60) in 5 transactions, worth $964K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 121,219 (-5.4%).

Value
$964K
Shares
66,015
Average price
$14.60
Role
Director
Holding change
-5.4%
Trade date
Nov 11, 2026 to Nov 12, 2026
5:13 PM ET 10-Q
Financial Results DataMeds AI, Inc. MEDS

DataMeds AI Q3 2026 Results: Turns Profitable, Net Income $10.6M

DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) reported a net income of $10.5 million for the quarter ended September 30, 2026, primarily driven by a $19.1 million gain on debt extinguishment. However, the company experienced a significant decline in nine-month revenues from $21.7 million in 2025 to $6.0 million in 2026, resulting in a year-to-date net loss of $15.6 million.

Key figure
Net income $10.6M
5:13 PM ET 8-K
Loan & Debt Booking Holdings Inc. BKNG

Booking Holdings Debt Financing Update with U.S. Bank Trust Company, National Association

Booking Holdings Inc. entered into an indenture for the sale of €1.25 billion in aggregate principal amount of senior notes. The transaction was executed via four Officers' Certificates under a base indenture with U.S. Bank Trust Company as trustee. The filing discloses the creation of a direct financial obligation related to these senior notes.

Counterparty
U.S. Bank Trust Company, National Association
5:12 PM ET 10-Q
Financial Results GRI Bio, Inc. GRI

GRI Bio Q3 2026 Results: Net Loss of $1.51M, Loss Narrows

GRI Bio, Inc. reported a net loss of $5.15 million for the nine months ended September 30, 2026, a significant reduction from the $9.30 million loss in the prior year period, primarily due to lower research and development expenses. The company strengthened its liquidity through an ATM offering, ending the period with $9.47 million in cash and cash equivalents. GRI Bio remains a clinical-stage biopharmaceutical company with an accumulated deficit of $56.84 million and no significant revenue.

Key figure
Net loss $1.51M
5:11 PM ET 10-Q
Financial Results Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals Q3 2026 Results: Net Loss of $183M, Loss Widens

Processa Pharmaceuticals reported a significant net loss of $189.8 million for the nine months ended September 30, 2026, primarily driven by a $178.0 million charge for acquired in-process research and development following the acquisition of Vidya Therapeutics. The company significantly strengthened its liquidity position during the period, ending with $180.2 million in cash and cash equivalents following a $200.0 million private placement financing.

Key figure
Net loss $183M
5:11 PM ET 10-Q
Financial Results Valor Energy Inc VAI

Valor Energy Q2 2026 Results: Net Loss of $8.05M, Loss Widens

Valor Energy Inc reported a significant net loss of $40.8 million for the six months ended September 30, 2026, primarily driven by a $34.1 million non-cash charge for the excess of warrant fair value over offering proceeds. Despite the loss, the company strengthened its cash position to $12.5 million following a $10.2 million net inflow from a Units Private Placement.

Key figure
Net loss $8.05M
5:10 PM ET Form 4
Insider Selling Venture Global, Inc. VG

Venture Global Senior VP, Development Fory Musser Sells $6.58M of Stock

Fory Musser, Senior VP, Development, sold 500,000 shares of Venture Global, Inc. at $13.16 a share, worth $6.58M in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).

Value
$6.58M
Shares
500,000
Price
$13.16
Role
Senior VP, Development
Holding change
-100.0%
Trade date
Nov 12, 2026
5:10 PM ET 8-K
Investor Presentation Health In Tech, Inc. HIT

Health In Tech Investor Presentation

Health In Tech, Inc. has prepared a formal investor presentation deck to be used by management at upcoming conferences and meetings. The presentation highlights the company's AI-powered marketplace platform designed to help small- and medium-sized businesses access self-funded health plans. The filing includes the full slide deck as Exhibit 99.1 for investor review.

5:10 PM ET Form 4
Insider Selling Monolithic Power Systems, Inc. MPWR

Monolithic Power Systems CFO Frank Anthony Balow III Sells $28.7K of Stock

Frank Anthony Balow III, CFO, sold 20 shares of Monolithic Power Systems, Inc. at $1,434.31 a share, worth $28.7K in total on Nov 11, 2026. Shares held after the trade: 2,921 (-0.7%).

Value
$28.7K
Shares
20
Price
$1,434.31
Role
CFO
Holding change
-0.7%
Trade date
Nov 11, 2026
5:09 PM ET 10-Q
Financial Results Astrotech Corp ASTC

Astrotech Q1 2026 Results: Net Loss of $2.95M, Loss Narrows

Astrotech reported a net loss of $2.9 million for the quarter ended September 30, 2026, compared to a $3.5 million loss in the prior year. Revenue decreased slightly to $274 thousand, while the company maintained a cash position of $5.6 million following an 'at-the-market' share issuance that raised $467 thousand.

Key figure
Net loss $2.95M
5:08 PM ET 8-K
Leadership Change Health In Tech, Inc. HIT

Health In Tech Leadership Change

Health In Tech, Inc. announced a leadership transition separating the roles of Executive Chairman and Chief Executive Officer. Founder Tim Johnson will serve as Executive Chairman focusing on long-term strategy and innovation, while Sanjay Shrestha has been appointed as the new CEO to lead day-to-day operations and commercial execution.

5:08 PM ET 10-Q
Financial Results Kairos Pharma, LTD. KAPA

Kairos Pharma Q3 2026 Results: Net Loss of $1.98M, Loss Widens

Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.

Key figure
Net loss $1.98M
5:07 PM ET 10-Q
Financial Results Cerenome, Inc. CNSY ▶ Call

Cerenome Q3 2026 Results: Net Loss of $8.66M, Loss Widens

Cerenome, Inc. reported a net loss of $24.6 million for the nine months ended September 30, 2026, compared to a $16.7 million loss in the prior year period. While the company introduced diagnostic revenue of $0.7 million, total revenue decreased due to lower grant revenue, and operating expenses nearly doubled to $25.8 million.

Key figure
Net loss $8.66M
5:07 PM ET 8-K
Financial Results Beasley Broadcast Group Inc BBGI

Beasley Broadcast Group Financial Results

Beasley Broadcast Group reported third quarter 2026 net revenue of $42.8 million, a 16.1% decrease year-over-year driven by weakness in national and local agency advertising. The company reported a net loss of $12.1 million for the quarter but highlighted improved digital operating margins of 32% and the completion of asset sales generating over $10 million in proceeds subsequent to quarter-end.

Term
Q3 2026
5:07 PM ET Form 4
Insider Buying Meridian Corp MRBK

Meridian Insider Kenneth Thomas Warriner Buys $16.2K of Stock

Kenneth Thomas Warriner bought 1,000 shares of Meridian Corp at $16.18 a share, worth $16.2K in total on Nov 13, 2026. Shares held after the trade: 4,050 (+32.8%).

Value
$16.2K
Shares
1,000
Price
$16.18
Holding change
+32.8%
Trade date
Nov 13, 2026
5:06 PM ET 8-K
Financial Results Health In Tech, Inc. HIT

Health In Tech Financial Results

Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.

Term
Q3 2026

“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”

Sanjay Shrestha, Chief Executive Officer of Health In Tech
5:06 PM ET 8-K/A
Investor Presentation Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics Investor Presentation

Intellia Therapeutics hosted a webcast and filed a formal investor presentation titled 'Readying Lonvo-z for Patients with HAE.' The presentation focused on the commercial potential and clinical data for lonvoguran ziclumeran (lonvo-z), a CRISPR-based therapy for hereditary angioedema.

5:05 PM ET 8-K
Executive Compensation National Health Investors Inc NHI

National Health Investors Executive Compensation

National Health Investors entered into new indemnification agreements with its directors and executive officers. The agreements obligate the company to indemnify these individuals to the maximum extent permitted by Maryland law for expenses and liabilities incurred due to their status as company officials, provided they acted in good faith. This is a standard corporate governance and compensatory arrangement to protect leadership from personal liability.

5:04 PM ET 10-Q
Financial Results Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Q3 2026 Results: Net Loss of $2.55M, Loss Widens

Cheetah Net Supply Chain Service Inc. reported a significant increase in revenue to $4.52 million for the nine months ended September 30, 2026, compared to $1.20 million in the prior year. Despite this growth, the company realized a net loss of $3.09 million, driven by high operating expenses and a $2.78 million loss related to the change in fair value of an acquisition-related contingent consideration asset.

Key figure
Net loss $2.55M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.